<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/872D8701-44D2-4D3C-B113-A795FA40D61F"><gtr:id>872D8701-44D2-4D3C-B113-A795FA40D61F</gtr:id><gtr:name>University of Helsinki</gtr:name><gtr:address><gtr:line1>Siltavuorenpenger 20 C</gtr:line1><gtr:line4>Helsinki</gtr:line4><gtr:line5>FI-00170</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8D6A87B-48C3-49DC-8D55-AA7203607683"><gtr:id>A8D6A87B-48C3-49DC-8D55-AA7203607683</gtr:id><gtr:name>University of British Columbia (UBC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90586AE8-B1B4-4D85-B7CC-B9130F248E5C"><gtr:id>90586AE8-B1B4-4D85-B7CC-B9130F248E5C</gtr:id><gtr:name>University of Nebraska-Lincoln</gtr:name><gtr:address><gtr:line1>University of Nebraska-Lincoln</gtr:line1><gtr:line4>Lincoln</gtr:line4><gtr:line5>Nebraska</gtr:line5><gtr:postCode>68588-0340</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Anatomy</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/872D8701-44D2-4D3C-B113-A795FA40D61F"><gtr:id>872D8701-44D2-4D3C-B113-A795FA40D61F</gtr:id><gtr:name>University of Helsinki</gtr:name><gtr:address><gtr:line1>Siltavuorenpenger 20 C</gtr:line1><gtr:line4>Helsinki</gtr:line4><gtr:line5>FI-00170</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8D6A87B-48C3-49DC-8D55-AA7203607683"><gtr:id>A8D6A87B-48C3-49DC-8D55-AA7203607683</gtr:id><gtr:name>University of British Columbia (UBC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90586AE8-B1B4-4D85-B7CC-B9130F248E5C"><gtr:id>90586AE8-B1B4-4D85-B7CC-B9130F248E5C</gtr:id><gtr:name>University of Nebraska-Lincoln</gtr:name><gtr:address><gtr:line1>University of Nebraska-Lincoln</gtr:line1><gtr:line4>Lincoln</gtr:line4><gtr:line5>Nebraska</gtr:line5><gtr:postCode>68588-0340</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BF47D388-B1EE-4B33-810A-0EA666A7BC05"><gtr:id>BF47D388-B1EE-4B33-810A-0EA666A7BC05</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>Leon</gtr:otherNames><gtr:surname>Collingridge</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F4AD6ADE-1675-400C-848E-8E1255496AF1"><gtr:id>F4AD6ADE-1675-400C-848E-8E1255496AF1</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Marrion</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C4B4329E-A731-4BC2-8CFC-7311340846E0"><gtr:id>C4B4329E-A731-4BC2-8CFC-7311340846E0</gtr:id><gtr:firstName>Elek</gtr:firstName><gtr:surname>Molnar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8464CB93-4656-4173-A343-F91F40FA7F7D"><gtr:id>8464CB93-4656-4173-A343-F91F40FA7F7D</gtr:id><gtr:firstName>Zuner</gtr:firstName><gtr:otherNames>Assis</gtr:otherNames><gtr:surname>Bortolotto</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9532377"><gtr:id>C03EB335-B61C-43AE-AFE6-CC3F1D1D90A6</gtr:id><gtr:title>Mechanisms of expression of NMDA receptor-dependent LTP and LTD in the hippocampus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9532377</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3710670</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK</gtr:description><gtr:id>B5694EE6-17BF-4BD5-8369-2A725344914F</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>069E17765F1-1</gtr:outcomeId><gtr:partnerContribution>provision of transgenic animals</gtr:partnerContribution><gtr:piContribution>Provision of transgenic animals</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of British Columbia</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>YT Wang</gtr:description><gtr:id>66D21B42-2A56-46DB-8DA0-0F58166B7415</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>CD93F562733-1</gtr:outcomeId><gtr:partnerContribution>Provision of experimental data</gtr:partnerContribution><gtr:piContribution>Provision of experimental data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Eli Lilly</gtr:description><gtr:id>A975F811-BD45-4CFF-8664-180862F45267</gtr:id><gtr:impact>New antagonists developed, eg UBP296</gtr:impact><gtr:outcomeId>63E3BB42A09-1</gtr:outcomeId><gtr:partnerContribution>screening of cloned receptors</gtr:partnerContribution><gtr:piContribution>Screening of cloned receptors for KAR antagonists</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Helsinki</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Sari Lauri</gtr:description><gtr:id>D97194D5-2B67-4F46-B78B-9A810E5325F6</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>84754EF5570-1</gtr:outcomeId><gtr:partnerContribution>experimental data</gtr:partnerContribution><gtr:piContribution>produced principal experimental data for publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Novartis</gtr:description><gtr:id>13A12285-9FF5-4FAB-8D73-FC96BA4B98B0</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>43D9776DA9C-1</gtr:outcomeId><gtr:partnerContribution>provision of NR selective antagonist</gtr:partnerContribution><gtr:piContribution>provision of antagonist</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nebraska?Lincoln</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Nebraska Medical Centre</gtr:department><gtr:description>DT Monaghan</gtr:description><gtr:id>62CDE654-F49F-4E99-A178-2FBCB86D2729</gtr:id><gtr:impact>Publications in relevant journals</gtr:impact><gtr:outcomeId>56dcc9de3c14d7.79008570-1</gtr:outcomeId><gtr:partnerContribution>Initial pharmacological characterisation of allosteric modulators using Xenopus Oocyte preparations.</gtr:partnerContribution><gtr:piContribution>Initial synthesis of novel compounds that act as NMDA receptor allosteric modulators. Analysis of effects on plasticty in in vitro slice preparations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Brain Awareness Week/Science Alive</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>11D6ABC7-BD3C-4B4F-B5B6-D68A4ECCB3C4</gtr:id><gtr:impact>Hands on activities in a local shopping centre where the general public could do activities and learn about the work we do.

Interest in our research</gtr:impact><gtr:outcomeId>AE5773856E5</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits - various</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>954124D3-DC2D-4858-AEB6-2922A088D5D6</gtr:id><gtr:impact>talks and activities about the brain and how memory works

Interst from school children</gtr:impact><gtr:outcomeId>D76485FEDAC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>public talks - various</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3D988648-C1FC-4B3C-A942-FBC4DE553813</gtr:id><gtr:impact>Talks to public audiences on aspects of our work

interst in our work</gtr:impact><gtr:outcomeId>1A0769ABECE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1866640</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3E728C69-7B39-4F3B-8238-0A9EF3E9BA13</gtr:id><gtr:outcomeId>1ECB45BE3C10</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Software to deliver stimuli and to analyse electrophysiological recordings</gtr:description><gtr:grantRef>G9532377</gtr:grantRef><gtr:id>3FD8579A-55C2-4BD9-A5C3-345F04084AE8</gtr:id><gtr:impact>Software is being used in laboratories across the world to further knowledge</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>51D7C3823BD</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>Win LTP software</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Software for the delivery of stimuli and e=analysis of electrophysiologigal data</gtr:description><gtr:id>2B24AA61-79AC-4FBC-8779-CB8EC31FA871</gtr:id><gtr:impact>adding to the research ability of labs across the world</gtr:impact><gtr:outcomeId>E68E3C0BFDA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Win LTP - software</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Software to perform electrophysiological experiments</gtr:description><gtr:id>1C1A68B5-0534-4BB4-B60A-7A862B797CD0</gtr:id><gtr:impact>This software is currently in use in a range of laboratories throughout the world</gtr:impact><gtr:outcomeId>545cb6ad060f68.72310227</gtr:outcomeId><gtr:title>WinLTP</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8AAD14ED-D8C3-484F-8E20-24125AD379B1</gtr:id><gtr:title>Characterisation of the effects of ATPA, a GLU(K5) kainate receptor agonist, on GABAergic synaptic transmission in the CA1 region of rat hippocampal slices.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7cf6f2563680186dae404931d4c7d0f"><gtr:id>f7cf6f2563680186dae404931d4c7d0f</gtr:id><gtr:otherNames>Clarke VR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>C1626CE8EC9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED7279C8-2850-491B-9F69-8E7683A14CD0</gtr:id><gtr:title>Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03ce74148e29f411bd07e7c7c0fcda07"><gtr:id>03ce74148e29f411bd07e7c7c0fcda07</gtr:id><gtr:otherNames>Plant K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>2DD04F5CBBF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E605E1B8-FE4B-4A13-8E54-A87EA8BC309B</gtr:id><gtr:title>Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f362519c22936b1e2c6849fb6a4c8a3"><gtr:id>6f362519c22936b1e2c6849fb6a4c8a3</gtr:id><gtr:otherNames>Collett VJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>0CBC83AF0BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99F314C9-6F93-4BA7-AE7A-A00DB0D536B1</gtr:id><gtr:title>LTP inhibits LTD in the hippocampus via regulation of GSK3beta.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25296974b6821f058afc51d5ccac2a48"><gtr:id>25296974b6821f058afc51d5ccac2a48</gtr:id><gtr:otherNames>Peineau S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>C7A3E29E958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A534A335-E666-4BD5-A300-A630F14B492A</gtr:id><gtr:title>Bi-directional modulation of AMPA receptor unitary conductance by synaptic activity.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3879dd20d277fe5cce4831e38872c424"><gtr:id>3879dd20d277fe5cce4831e38872c424</gtr:id><gtr:otherNames>L?thi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>05A16A8AE89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62BCBC4C-753A-4416-AF8B-B50A93825DB1</gtr:id><gtr:title>Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f60051e9db58e4e8a59e6acb2f2659f"><gtr:id>6f60051e9db58e4e8a59e6acb2f2659f</gtr:id><gtr:otherNames>Massey PV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>1BCD5931CF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE3272D9-7281-40B0-9F4C-8D3D5D0F0B46</gtr:id><gtr:title>Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/364b15fc5ae96fbed70445d1d2fb7bf7"><gtr:id>364b15fc5ae96fbed70445d1d2fb7bf7</gtr:id><gtr:otherNames>Bartlett TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>9D2160C2C32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53C2F23C-482E-4190-94C3-5851C498CEB0</gtr:id><gtr:title>The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10fb1f878664cbaa9ca7a7f7c164bd16"><gtr:id>10fb1f878664cbaa9ca7a7f7c164bd16</gtr:id><gtr:otherNames>Bortolotto ZA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>49C4B5F01AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>988AFB19-3BEE-4914-98F3-A2109A084EE9</gtr:id><gtr:title>Multiple, developmentally regulated expression mechanisms of long-term potentiation at CA1 synapses.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b61d75f7819a3780ee587e367b12a9"><gtr:id>f9b61d75f7819a3780ee587e367b12a9</gtr:id><gtr:otherNames>Palmer MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>663DA243A46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2733842-B602-42B8-B04F-BDBF32A5D066</gtr:id><gtr:title>Hippocalcin functions as a calcium sensor in hippocampal LTD.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e23f6c64bb0a5f38e7a7d992e41a3b"><gtr:id>c5e23f6c64bb0a5f38e7a7d992e41a3b</gtr:id><gtr:otherNames>Palmer CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>49E175C04EA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02CA1118-AFB7-4B11-8F31-7C928B75DCBB</gtr:id><gtr:title>Endogenous activation of kainate receptors regulates glutamate release and network activity in the developing hippocampus.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a0cd335843ba72fbd6315752eb26583"><gtr:id>0a0cd335843ba72fbd6315752eb26583</gtr:id><gtr:otherNames>Lauri SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>3C8B72E973A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01AAB37B-1A6C-4DA8-BB06-A9170070DF96</gtr:id><gtr:title>Tyrosine phosphatases regulate AMPA receptor trafficking during metabotropic glutamate receptor-mediated long-term depression.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b776dfe698d77f95889b417812608a15"><gtr:id>b776dfe698d77f95889b417812608a15</gtr:id><gtr:otherNames>Moult PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>95B6E7F1D60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19485C85-C18D-470B-B077-2E02E2205BE6</gtr:id><gtr:title>Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6782b8d792dd00f7fb03bfa38fc59c05"><gtr:id>6782b8d792dd00f7fb03bfa38fc59c05</gtr:id><gtr:otherNames>Thuault SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>DCDFE7652AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2DDEC2F-30D6-4E8D-B00D-EDBBA8F9C52D</gtr:id><gtr:title>Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccfbe3010533a5f45f491ef9ace877dd"><gtr:id>ccfbe3010533a5f45f491ef9ace877dd</gtr:id><gtr:otherNames>Anderson WW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>813D59FF255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF48A0DA-BDD2-4801-8724-089419196ECB</gtr:id><gtr:title>Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f84c771e11ed7b214320b224cc8a61ad"><gtr:id>f84c771e11ed7b214320b224cc8a61ad</gtr:id><gtr:otherNames>More JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>1CD1FD3DBC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C24B8481-26A1-41CF-9C82-93CAF0119011</gtr:id><gtr:title>Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice.</gtr:title><gtr:parentPublicationTitle>Hippocampus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c1b65c02d2ead34c6c2f368700c538a"><gtr:id>6c1b65c02d2ead34c6c2f368700c538a</gtr:id><gtr:otherNames>Brown JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1050-9631</gtr:issn><gtr:outcomeId>0C9DDF46430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BDA6A51-1BCA-467D-A612-A8FE768E0519</gtr:id><gtr:title>The GABA(B2) subunit is critical for the trafficking and function of native GABA(B) receptors.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6782b8d792dd00f7fb03bfa38fc59c05"><gtr:id>6782b8d792dd00f7fb03bfa38fc59c05</gtr:id><gtr:otherNames>Thuault SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>4B80DCB7D6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60A331AB-097F-4625-85B1-CC8738D0432F</gtr:id><gtr:title>Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3a6822d61ed9e993c609431e7d20d74"><gtr:id>b3a6822d61ed9e993c609431e7d20d74</gtr:id><gtr:otherNames>Dolman NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>7E4549AED63</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9532377</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>